Looking to Position Yourself as a Leader Within the Dry AMD & GA Development Space?
The ever-growing ophthalmic community continue to strive for durable, safe and accessible treatments for dry AMD and GA. To achieve this biopharma are actively seeking collaborations with solution providers to accelerate development.
The Dry AMD & GA therapeutics Summit offers a unique opportunity to connect with decision-makers from small and large biotech, pharma and academia, to spark connections, foster relationships and demonstrate your commitment to the shared objective of reducing central vision loss.
Download the event guide to learn more about how you can showcase your brand to the audience of leading companies with active pipelines in dry AMD and ophthalmic diseases.
Why Partner in 2025?
Bespoke Networking Opportunities - Gain the confidence of and secure valuable facetime with key influencers propelling AMD therapeutic development who are in search of ophthalmology technologies and screening tools
Brand Exposure - Position your brand prominently and showcase your solutions to visual disease experts through pre-conference and conference advertising
Cutting Edge Research - Keep your finger on the pulse and stay ahead of the curve about how the dry AMD & GA fields moving
Deliver a Presentation - Influence the thinking of ophthalmic decision makers who are looking for the tools to drive success in the lab
What Experts Need from You:
- Precise ocular delivery technologies
- AI algorithm for AMD monitoring
- Optical biomarkers
- Diagnostics devices that drive accuracy such as fundus imaging systems, perimeters and handheld rebound tonometers
- Preclinical CROs focused on ophthalmic studies
- Clinical CROs specialised in vision research
- Pathologically accurate models
Who You Will Meet?
